Verastem (VSTM) Operating Expenses (2011 - 2026)

Verastem's Operating Expenses history runs 16 years deep, the most recent figure standing at $63.6 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 43.9% year-over-year to $63.6 million; the TTM figure through Mar 2026 stood at $220.4 million (up 56.26% YoY), while the FY2025 annual figure was $201.0 million, up 60.89% from the prior year.
• Operating Expenses was $63.6 million for Q1 2026 at Verastem, up from $59.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $63.6 million in Q1 2026 to a low of $16.8 million in Q4 2022.
• Historically, Operating Expenses has averaged $32.8 million across 5 years, with a median of $28.3 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses retreated 5.19% in 2023, then soared 86.8% in 2025.
• A 5-year view of Operating Expenses shows it stood at $16.8 million in 2022, then surged by 84.85% to $31.1 million in 2023, then gained by 1.45% to $31.6 million in 2024, then jumped by 86.8% to $59.0 million in 2025, then rose by 7.72% to $63.6 million in 2026.
• The last three Operating Expenses figures came in at $63.6 million (Q1 2026), $59.0 million (Q4 2025), and $52.0 million (Q3 2025), per Business Quant data.